By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ASPiRA LABS 

12117 Bee Caves Road
Building III, Suite 100
Austin  Texas  78738  U.S.A.
Phone: 512-519-0400 Fax: 512-439-6980


SEARCH JOBS

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases. The company's initial in vitro diagnostic test, OVA1®, was the first FDA-cleared, protein-based In Vitro Diagnostic Multivariate Index Assay, and represented a new class of software-based liquid biopsy in vitro diagnostics. In March 2016 Vermillion received FDA clearance for Overa, a second generation OVA1 test with significantly improved specificity and ease of use. For additional information, including published clinical trials, visit www.vermillion.com.

YEAR FOUNDED:

1993

LEADERSHIP:

CEO: Valerie B. Palmieri


Key Statistics


Email: info@vermillion.com
Ownership: Private

Web Site: ASPiRA LABS
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
Vermillion Release: ASPiRA LABS Announces TriCare South Contract 3/30/2017 8:14:02 AM
ASPiRA LABS Announces Provider Status With Medi-Cal Expanding OVA1 Access To Over 12 Million Beneficiaries 3/7/2017 9:36:29 AM
ASPiRA LABS Announces Contracted In-Network Agreement With Blue Cross Blue Shield Of Michigan For OVA1 3/2/2017 6:45:35 AM
Vermillion And ASPiRA LABS Announce Receipt Of Formal FDA Clarification Regarding Ovarian Cancer Screening Alert 1/5/2017 9:50:00 AM
ASPiRA LABS' OVA1 Technology Receives "Level B" Recommendation In The Latest ACOG Clinical Management Guidelines For The Management Of Adnexal Masses 11/11/2016 12:19:52 PM
Vermillion And ASPiRA LABS Applaud The FDA's Position On Ovarian Cancer Screening 9/9/2016 10:48:41 AM
ASPiRA LABS Partners With New York Yankees Manager Joe Girardi For Ovarian Cancer Awareness Campaign Promoting Earlier Diagnosis 9/7/2016 11:10:06 AM
ASPiRA LABS Expands Coverage For OVA1 In California 8/3/2016 8:16:56 AM
//-->